The metastasis associated protein S100A4: role in tumour progression and metastasis - PubMed (original) (raw)
Review
The metastasis associated protein S100A4: role in tumour progression and metastasis
D M Helfman et al. Br J Cancer. 2005.
Abstract
The metastasis associated protein S100A4 is a small calcium binding protein that is associated with metastatic tumors and appears to be a molecular marker for clinical prognosis. Below we discuss its biochemical properties and possible cellular functions in metastasis including cell motility, invasion, apoptosis, angiogenesis and differentiation.
Similar articles
- S100A4 and metastasis: a small actor playing many roles.
Boye K, Maelandsmo GM. Boye K, et al. Am J Pathol. 2010 Feb;176(2):528-35. doi: 10.2353/ajpath.2010.090526. Epub 2009 Dec 17. Am J Pathol. 2010. PMID: 20019188 Free PMC article. Review. - S100A4 expression is closely linked to genesis and progression of glioma by regulating proliferation, apoptosis, migration and invasion.
Jin T, Zhang Z, Yang XF, Luo JS. Jin T, et al. Asian Pac J Cancer Prev. 2015;16(7):2883-7. doi: 10.7314/apjcp.2015.16.7.2883. Asian Pac J Cancer Prev. 2015. PMID: 25854377 - S100A4 silencing suppresses proliferation, angiogenesis and invasion of thyroid cancer cells through downregulation of MMP-9 and VEGF.
Jia W, Gao XJ, Zhang ZD, Yang ZX, Zhang G. Jia W, et al. Eur Rev Med Pharmacol Sci. 2013 Jun;17(11):1495-508. Eur Rev Med Pharmacol Sci. 2013. PMID: 23771538 - Metastasis-associated protein S100A4: spotlight on its role in cell migration.
Tarabykina S, Griffiths TR, Tulchinsky E, Mellon JK, Bronstein IB, Kriajevska M. Tarabykina S, et al. Curr Cancer Drug Targets. 2007 May;7(3):217-28. doi: 10.2174/156800907780618329. Curr Cancer Drug Targets. 2007. PMID: 17504119 Review. - Knockdown of S100A4 decreases tumorigenesis and metastasis in osteosarcoma cells by repression of matrix metalloproteinase-9.
Zhang G, Li M, Jin J, Bai Y, Yang C. Zhang G, et al. Asian Pac J Cancer Prev. 2011;12(8):2075-80. Asian Pac J Cancer Prev. 2011. PMID: 22292654
Cited by
- Sarcomatoid renal cell carcinoma: biology, natural history and management.
Blum KA, Gupta S, Tickoo SK, Chan TA, Russo P, Motzer RJ, Karam JA, Hakimi AA. Blum KA, et al. Nat Rev Urol. 2020 Dec;17(12):659-678. doi: 10.1038/s41585-020-00382-9. Epub 2020 Oct 13. Nat Rev Urol. 2020. PMID: 33051619 Free PMC article. Review. - Epigenetic deregulation of multiple S100 gene family members by differential hypomethylation and hypermethylation events in medulloblastoma.
Lindsey JC, Lusher ME, Anderton JA, Gilbertson RJ, Ellison DW, Clifford SC. Lindsey JC, et al. Br J Cancer. 2007 Jul 16;97(2):267-74. doi: 10.1038/sj.bjc.6603852. Epub 2007 Jun 19. Br J Cancer. 2007. PMID: 17579622 Free PMC article. - S100A4/non-muscle myosin II signaling regulates epithelial-mesenchymal transition and stemness in uterine carcinosarcoma.
Tochimoto M, Oguri Y, Hashimura M, Konno R, Matsumoto T, Yokoi A, Kodera Y, Saegusa M. Tochimoto M, et al. Lab Invest. 2020 May;100(5):682-695. doi: 10.1038/s41374-019-0359-x. Epub 2019 Dec 19. Lab Invest. 2020. PMID: 31857700 - A high-efficiency differential expression method for cancer heterogeneity using large-scale single-cell RNA-sequencing data.
Yuan X, Ma S, Fa B, Wei T, Ma Y, Wang Y, Lv W, Zhang Y, Zheng J, Chen G, Sun J, Yu Z. Yuan X, et al. Front Genet. 2022 Nov 29;13:1063130. doi: 10.3389/fgene.2022.1063130. eCollection 2022. Front Genet. 2022. PMID: 36523772 Free PMC article. - ZEB1 and IL-6/11-STAT3 signalling cooperate to define invasive potential of pancreatic cancer cells via differential regulation of the expression of S100 proteins.
Al-Ismaeel Q, Neal CP, Al-Mahmoodi H, Almutairi Z, Al-Shamarti I, Straatman K, Jaunbocus N, Irvine A, Issa E, Moreman C, Dennison AR, Emre Sayan A, McDearmid J, Greaves P, Tulchinsky E, Kriajevska M. Al-Ismaeel Q, et al. Br J Cancer. 2019 Jul;121(1):65-75. doi: 10.1038/s41416-019-0483-9. Epub 2019 May 24. Br J Cancer. 2019. PMID: 31123345 Free PMC article.
References
- Ambartsumian N, Klingelhofer J, Grigorian M, Christensen C, Kriajevska M, Tulchinsky E, Georgiev G, Berezin V, Bock E, Rygaard J, Cao R, Yihai CaoY, Lukanidin E (2001) The metastasis-associated Mts1(S100A4) protein could act as an angiogenic factor. Oncogene 20: 4685–4695 - PubMed
- Ambartsumian N, Grigorian M, Larse I, Karlstrøm O, Sidenius N, Rygaard J, Georgiev G, Lukanidin E (1996) Metastasis of mammary carcinomas in GRS/A hybrid mice transgenic for the mts 1 gene. Oncogene 13: 1621–1630 - PubMed
- Belot N, Pochet R, Heizmann CW, Kiss R, Decaestecker C (2002) Extracellular S100A4 stimulates the migration rate of astrocytic tumor cells by modifying the organization of their actin cytoskeleton. BBA 1600: 74–83 - PubMed
- Bjornland K, Winberg JO, Odegaard OT, Hovig E, Loennechen T, Aasen AO, Fodstad O, Maelandsmo GM (1999) S100A4 involvement in metastasis: deregulation of matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases in osteosarcoma cells transfected with an anti-S100A4 ribozyme. Cancer Res 59: 4702–4708 - PubMed
- Chen H, Fernig DG, Rudland PS, Sparks A, Wilkinson MC, Barraclough R (2001) Binding to intracellular targets of the metastasis-inducing protein, S100A4 (p9Ka). Biochem Biophys Res Commun 286(5): 1212–1217 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials